Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |